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Abstract - A wide variety of antimicrobial cationic agents, such as chlorhexidine gluconate, are commonly used in antisep-
tic preparations in the prevention of nosocomial infections caused by methicillin-resistant Staphylococcus aureus (MRSA). 
In this study was investigated the activity of chlorhexidine gluconate against MRSA and methicillin-sensitive Staphylococ-
cus aureus (MSSA). The quantitative suspension test was carried out with 1% and 4% chlorhexidine gluconate and contact 
time of 30 s, 60 s and 120 s. Since the plasmid-borne gene qacA/B confers resistance to cationic antiseptic agents in S. 
aureus, activity was also examined with regard to the presence of qacA/B. The results indicate that neither 1% nor 4% chlo-
rhexidine gluconate achieved a log10 reduction factors (RF) >5 against MRSA and MSSA strains at 30 s, 60 s and 120 s. At 
all concentrations, the RF for MRSA qacA/B negative strains were significantly higher when compared to MRSA qacA/B 
positive strains at 60 s and 120 s.
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INTRODUCTION
The  methicillin-resistant  Staphylococcus  aureus 
(MRSA) strains have become one of the most im-
portant nosocomial pathogens causing a wide range 
of  diseases,  from  localized  skin  infections  to  life-
threatening conditions such as pneumonia and en-
docarditis (Hiramatsu et al., 2001; Shamsudin et al., 
2012). Since the hands of healthcare workers are the 
major source of transmission of nosocomial patho-
gens, treatment of hands with appropriate antiseptics 
is the most important measure to be taken in break-
ing the chain of transmission (Goroncy-Bermes et 
al., 2001). In both the United Kingdom and United 
States,  antiseptic  soaps  and  scrubs  containing  2% 
and 4% chlorhexidine are mainly available for this 
purpose (Goroncy-Bermes et al., 2001).
Excessive use of antiseptic agents may result in 
the emergence of MRSA with reduced antiseptic sus-
ceptibility or even antiseptic resistance. At least 12 
antiseptic resistance genes (qacA to qacJ, smr and 
norA) have been identified in Staphylococcus species, 
of which four (qacA, qacB, qacC and norA) are found 
mainly in clinical isolates of S. aureus (Noguchi et 
al., 2006). The qacA gene, located on chromosomes 
and on plasmids (pSK1 family), confers resistance to 
monovalent cations (ethidium, benzalkonium, cet-
rimide) and divalent cations (chlorhexidine, penta-950 DOLORES OPAČIĆ ET AL.
midine). The qacB gene, located on several plasmids 
such as β-lactamase and heavy metal-resistance plas-
mids (pSK23), confers resistance to monovalent cati-
ons and at low levels to some divalent compounds. 
Both determinants have been identified to confer re-
sistance by means of proton motive force-dependent 
multidrug efflux (Paulsen et al., 1997).
The aim of the study was to determine the an-
timicrobial activity of chlorhexidine gluconate (1% 
and 4%) against MRSA and MSSA strains.
MATERIALS AND METHODS
A total of 100 randomly collected clinical strains of 
S. aureus, isolated from blood cultures and swabs, 
were used in this study. By polymerase chain reac-
tion (PCR), the mecA gene was detected in 50 (50%) 
strains, which confirms that they were MRSA. The 
presence of qacA/B genes was also determined by 
PCR as shown previously (Opačić et al., 2010).
To  determine  the  antimicrobial  (bactericidal) 
activity of chlorhexidine gluconate, the quantitative 
suspension test was carried out according to Kampf 
et al. (1998). Briefly, per 0.1 mL of bacterial suspen-
sion  was  transferred  to  a  control  tube  containing 
9.9 mL sterile water (diluent) and to a reaction tube 
containing 9.9 mL antiseptic. The contact times were 
30 s, 60 s and 120 s, as the biocides chosen for this 
study are used mainly as skin antiseptics and there-
fore have to be effective within a short time. After 
the contact times, a 10-fold dilution was made in 
the tube containing the neutralizer (combination of 
Tween 80 (3%), L-histidine (0.1%) and sodium thio-
sulfate (0.5%)). The combination of Tween 80 (3%), 
L-histidine  (0.1%)  and  sodium  thiosulfate  (0.5%) 
was used to neutralize the activity of chlorhexidine 
gluconate.
Four further 10-fold dilutions were then made in 
the tubes containing the diluent. Aliquots were trans-
ferred from each tube to sheep blood agar plates and 
spread over the agar. The plates were incubated at 37° 
C for 24 h. Water (six 10-fold dilutions) and neutral-
izer served as a control. Tests were run in duplicate. 
Colony forming units (cfu) were counted from all 
plates and the means were calculated for each experi-
ment. Reduction factors (RF) were calculated using 
the following formula: F = log10cfu (control) - log10cfu 
(antiseptic). Log10 reductions of >5 were taken as in-
dicative of satisfactory bactericidal activity.
Statistics
Data were compared using the t test; p ≤ 0.05 were 
significant.
RESULTS
Chlorhexidine gluconate (1%) was not bactericidal 
(RF<5) for MRSA and MSSA at 30 s, 60 s and 120 s. 
At a concentration of 4%, RF<5 were also observed 
against MRSA and MSSA at all contact times. How-
ever, at both concentrations, the RF for MSSA were 
higher when compared to MRSA (p>0.05) at 120 s 
(Table 1). In a previous study (Opačić et al., 2010), 
the qacA/B gene, responsible for the resistance to 
monovalent  and  divalent  cations,  was  detected  in 
17 of the total 100 strains (17%): in 16 out of the 
50 MRSA (32%) and in 1 out of the 50 MSSA (2%) 
strains, p<0.05. At all concentrations, the reduction 
factors for MRSA qacA/B negative strains were sig-
nificantly higher when compared to MRSA qacA/B 
positive strains at 60 s and 120 s, p<0.05 (Table 2). 
Irrespective of the contact time, the RF for MSSA 
qacA/B negative strains were not significantly higher 
when compared to MSSA qacA/B positive strains, 
p>0.05 (Table 3).
DISCUSSION
In a hospital setting, S. aureus including MRSA 
may  produce  bloodstream  and  surgical-site  infec-
tions causing human infections of the skin and soft 
tissues, bones and joints, normal heart valves and ab-
scesses. In addition to MSSA, MRSA is now a huge 
burden  for  most  healthcare  institutions  and  is  by 
far the most significant antibiotic-resistant acquired 
pathogen the world has ever encountered (European 
Antimicrobial Resistance Surveillance System, 2005). 
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staff in healthcare centers is known as a source of 
outbreaks of nosocomial infections and might be sig-
nificantly reduced by the use of antiseptics (Messager 
et al., 2001).
Chlorhexidine gluconate has been incorporated 
into a number of hand-hygiene preparations. Aque-
ous  or  detergent  formulations  containing  0.5%  or 
0.75% chlorhexidine are more effective than plain 
Table 1. Comparative activity of chlorhexidine gluconate (1% and 4%) against methicillin-resistant Staphylococcus aureus (MRSA) and 
methicillin-sensitive Staphylococcus aureus (MSSA) at various contact times (30 s, 60 s and 120 s).
Concentration of
chlorhexidine gluconate
Contact
time
Mean  RF* p value
MRSA MSSA
1% 30 s 0.19 0.16 0.261
60 s 0.38 0.38 0.948
120 s 0.69 0.72 0.644
4% 30 s 0.30 0.25 0.267
60 s 0.51 0.51 0.974
120 s 0.88 0.94 0.501
* Mean of reduction factors (N=50)
Table 2. Comparative activity of chlorhexidine gluconate (1% and 4%) against methicillin-resistant Staphylococcus aureus (MRSA) with 
regard to the qacA/B gene at various contact times (30 s, 60 s and 120 s).
Concentration of
chlorhexidine gluconate
Contact
time
Mean  RF* p value
MRSA MRSA
qacA/B- qacA/B+
1% 30 s 0.22 0.14 0.066
60 s 0.43 0.29 0.026
120 s 0.77 0.52 0.007
4% 30 s 0.34 0.22 0.091
60 s 0.57 0.37 0.016
120 s 0.96 0.72 0.028
* Mean of reduction factors (N=50)
Table 3. Comparative activity of chlorhexidine gluconate (1% and 4%) against methicillin-sensitive Staphylococcus aureus (MSSA) with 
regard to the qacA/B gene at various contact times (30 s, 60 s and 120 s).
Concentration of
chlorhexidine gluconate
Contact
time
Mean  RF* p value
MSSA MSSA
qacA/B- qacA/B+
1% 30 s 0.16 0.02 0.273
60 s 0.39 0.08 0.278
120 s 0.72 0.52 0.619
4% 30 s 0.25 0.11 0.469
60 s 0.51 0.14 0.268
120 s 0.94 0.75 0.682
* Mean of reduction factors (N=50)952 DOLORES OPAČIĆ ET AL.
soap, but they are less effective than antiseptic deter-
gent preparations containing 4% chlorhexidine glu-
conate. Preparations with 2% chlorhexidine gluco-
nate are slightly less effective than those containing 
4% chlorhexidine (Lowbury and Lilly, 1973; Paulson, 
1994).
The effect of chlorhexidine-containing scrubs on 
microorganisms is controversial. Although the an-
timicrobial efficacy of this active agent was demon-
strated by some investigators, others recorded resist-
ance to chlorhexidine, especially in the case of gram-
negative  species.  However,  a  limited  effectiveness 
of chlorhexidine has also been shown with MRSA 
(Goroncy-Bermes  et  al.,  2001).  Suller  and  Russell 
(1999) showed MRSA strains to be less susceptible 
than MSSA to chlorhexidine. In contrast, Baddour 
(2008) described a remarkably pronounced effect of 
chlorhexidine against both MRSA and MSSA.
Against  MRSA,  the  chlorhexidine-containing 
scrub  and  the  nonmedicated  handwash  products 
were significantly less active (log10 RF values of 1.00 
and 2.60, respectively), whereas the alcoholic hand 
disinfectant demonstrated the highest activity (log10 
RF=5.22). In fact, 2% chlorhexidine was not suffi-
ciently effective against MRSA at the recommend-
ed contact time of 1 minute as was the case with 
vancomycin-resistant  enterococci  and  high-level 
gentamicin-resistant enterococci (Goroncy-Bermes 
et al., 2001). Neither chlorhexidine detergent scrub 
(4%) nor liquid soap (20% palm oil and potassium 
fatty  acid)  was  completely  effective  in  removing 
MRSA from contaminated fingertips (Huang et al., 
1994). On the other hand, at a concentration of 2%, 
log10 RF>5 was observed against MSSA at 30 s, 60 s 
and 5 min and against MRSA only after 60 s and 5 
min. At all mentioned reaction times, chlorhexidine 
gluconate (4%) was highly bactericidal (log10 RF>5) 
for MRSA and MSSA (Kamf et al., 1998), which is in 
contrast to the results of this study.
The varying effect of chlorhexidine upon clinical 
strains, as observed in different tests, is of importance 
as it may mean that certain strains will have an ability 
to survive chlorhexidine treatment and that the use 
of biocides could act as a selective pressure to allow 
these strains to predominate (Vali et al., 2008). Many 
investigators call attention to the fact that the qacA/B 
genes are present in 47.9%, 63%, 80% and 83.3% of 
Japanese, European, Brazilian and Malaysian clini-
cal MRSA strains, respectively (Noguchi et al., 2005; 
Mayer et al., 2001; Miyazaki et al., 2007; Shamsudin 
et al., 2012). In addition, qacA/B genes are detect-
ed in 2 (4%) of 50 MSSA strains (Nakipoģlu et al., 
2012). Since nucleotide sequencing analysis revealed 
the  presence  of  two  genetic  variants  in  qacA  (V1 
and V2) and four variants in qacB (V1-V4), some 
findings revealed that qacA and qacB are prevalent 
in MRSA and that variable genetic variants of these 
genes may be responsible for the different resistance 
levels against antiseptic substances (Alam, 2003).
In conclusion, this study gives insight into the 
activity of chlorhexidine gluconate (1% and 4%) with 
insignificant differences between their effects against 
methicillin-resistant and -sensitive S. aureus strains.
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